109 related articles for article (PubMed ID: 4011619)
1. Recent trends in veterinary vaccines.
Bittle JL
Prog Clin Biol Res; 1985; 178():621-6. PubMed ID: 4011619
[TBL] [Abstract][Full Text] [Related]
2. Recent developments in veterinary vaccinology.
Shams H
Vet J; 2005 Nov; 170(3):289-99. PubMed ID: 16266843
[TBL] [Abstract][Full Text] [Related]
3. [Biotechnology for the benefit of vaccination against viral diseases: a review].
van Oirschot JT
Tijdschr Diergeneeskd; 2002 Jan; 127(1):7-16. PubMed ID: 11795035
[TBL] [Abstract][Full Text] [Related]
4. [Molecular biology of paramyxoviruses and its significance for the development of vaccines].
Scheid A
Internist (Berl); 1985 Feb; 26(2):98-102. PubMed ID: 3884533
[No Abstract] [Full Text] [Related]
5. Novel vaccines from biotechnology.
Rogan D; Babiuk LA
Rev Sci Tech; 2005 Apr; 24(1):159-74. PubMed ID: 16110886
[TBL] [Abstract][Full Text] [Related]
6. Production of veterinary vaccines in the Sudan.
Babiker SH
Berl Munch Tierarztl Wochenschr; 1996 Jan; 109(1):8-9. PubMed ID: 8593158
[TBL] [Abstract][Full Text] [Related]
7. Conclusions--future trends in veterinary vaccinology.
Pastoret PP; Schudel AA; Lombard M
Rev Sci Tech; 2007 Aug; 26(2):489-94, 495-501, 503-9. PubMed ID: 17892169
[No Abstract] [Full Text] [Related]
8. Present knowledge of poliovirus and perspectives for future vaccines.
Crainic R; Blondel B
Dev Biol Stand; 1987; 66():377-83. PubMed ID: 3034705
[TBL] [Abstract][Full Text] [Related]
9. Experience with veterinary vaccines in warm climates.
Tulasne JJ; Lefèvre PC; Blancou J
Dev Biol Stand; 1996; 87():33-42. PubMed ID: 8854000
[TBL] [Abstract][Full Text] [Related]
10. Marker vaccines and the impact of their use on diagnosis and prophylactic measures.
Vannie P; Capua I; Le Potier MF; Mackay DK; Muylkens B; Parida S; Paton DJ; Thiry E
Rev Sci Tech; 2007 Aug; 26(2):351-72. PubMed ID: 17892157
[TBL] [Abstract][Full Text] [Related]
11. Development of new concepts in vaccines and their effects on the control of infectious diseases (classical swine fever in particular).
Vannier P
Dev Biol (Basel); 2004; 119():235-41. PubMed ID: 15742634
[TBL] [Abstract][Full Text] [Related]
12. Marker vaccine strategies and candidate CSFV marker vaccines.
Dong XN; Chen YH
Vaccine; 2007 Jan; 25(2):205-30. PubMed ID: 16934915
[TBL] [Abstract][Full Text] [Related]
13. [DNA vaccines for veterinary medicine].
Gerdts V; Mettenleiter TC
Dtsch Tierarztl Wochenschr; 2001 Jan; 108(1):3-10. PubMed ID: 11232422
[TBL] [Abstract][Full Text] [Related]
14. Production and antigenic effect of experimental sheep adenovirus vaccines.
Pálfi V; Belák S
Acta Microbiol Acad Sci Hung; 1980; 27(2):135-9. PubMed ID: 7415875
[TBL] [Abstract][Full Text] [Related]
15. Recombinant DNA technology for the preparation of subunit vaccines.
Bachrach HL
J Am Vet Med Assoc; 1982 Nov; 181(10):992-9. PubMed ID: 6129235
[TBL] [Abstract][Full Text] [Related]
16. Bluetongue vaccines: the past, present and future.
Bhanuprakash V; Indrani BK; Hosamani M; Balamurugan V; Singh RK
Expert Rev Vaccines; 2009 Feb; 8(2):191-204. PubMed ID: 19196199
[TBL] [Abstract][Full Text] [Related]
17. Review of attenuated live virus-vaccines in use in Iraq.
Ayar K
Bull Off Int Epizoot; 1966 May; 66(1):747-8. PubMed ID: 6011927
[No Abstract] [Full Text] [Related]
18. The threat of peste des petits ruminants: progress in vaccine development for disease control.
Diallo A; Minet C; Le Goff C; Berhe G; Albina E; Libeau G; Barrett T
Vaccine; 2007 Jul; 25(30):5591-7. PubMed ID: 17399862
[TBL] [Abstract][Full Text] [Related]
19. Strategies of constructing recombinant vaccines.
Sałamaszyńska-Guz A; Klimuszko D
Pol J Vet Sci; 2009; 12(1):133-9. PubMed ID: 19459451
[TBL] [Abstract][Full Text] [Related]
20. Studies on vaccination of chicks with HVT against Marek's disease.
Rana UV; Negi SK; Sharma SN
J Commun Dis; 1984 Sep; 16(3):234-9. PubMed ID: 6096443
[No Abstract] [Full Text] [Related]
[Next] [New Search]
